Other current positions
- Managing Partner at Pureos Partners AG, a venture capital firm specializing in early-stage financing to support innovative young drug development companies with a focus on Switzerland and Europe, since 2017
- Member of the Board of Directors of Pureos Bioventures 2 GP, Guernsey, since 2022
- Member of the Board of Directors of BB Pureos Bioventures GP, Guernsey, since 2018
- Member of the Board of Directors of Cascination AG, Bern, since 2025
- Observer on the Board of Directors, Citryll B.V., Oss, Netherlands, since 2024
- Member of the Board of Directors of River 2 Renal Corp. and River 3 Renal Corp., New York/USA, since 2021
Previous positions and professional experience
- Member of the Board of Directors of Ariceum Therapeutics, Germany, until 2025
- Member of the Board of Directors of Alentis Therapeutics AG, Basel, until 2024
- Various board mandates at early-stage companies in Europe and the U.S.
- Various roles at venture capital firms in Switzerland
Education
- ETH Zurich, postgraduate studies in economics, business administration, and management
- ETH Zurich, Ph.D. in Protein Chemistry
- ETH Zurich, Natural Sciences
